基本信息
views: 7
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Vagner Rigaud is a Research Scientist II in the Cardiovascular Disease Initiative at the Broad Institute of MIT and Harvard. He currently works as a project leader in the Broad-Bayer collaboration characterizing and validating novel therapeutic candidates for the treatment of heart diseases.
Rigaud obtained his Ph.D. from the Heart Institute of the Universidade de São Paulo (Brazil). He received postdoctoral training at the Universidade de Coimbra (Portugal) and Temple University developing RNA-based therapeutics for heart regeneration and has been recognized with several awards including the AHA Postdoctoral Fellowship and the highly prestigious AHA Melvin L. Marcus Early Career Investigator Award. Rigaud also holds an M.Sc. in Biomedical Sciences from Universidade de São Paulo.
Research Interests
Papers共 47 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Omar Asdrúbal Vilca Mejia, Renato Cesar de Souza,Aritania S. Santos, Bianca Meneghini,Ana Carolina Carvalho Silva, Guilherme Visconde Brasil,Vagner Oliveira Carvalho Rigaud,Luís Roberto Palma Dallan,Luiz Felipe Pinho Moreira,Luiz Augusto Ferreira Lisboa,Luís Alberto Oliveira Dallan,Jorge Kalil,
Cited0Views0Bibtex
0
0
Circulation Researchno. Suppl_1 (2022)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn